APA (7th ed.) Citation

Kim, H., Kim, R., Jo, H., Kim, H. R., Hong, J., Ha, S. Y., . . . Kim, S. T. (2022). Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer. Therapeutic Advances in Gastroenterology, 15, 1. https://doi.org/10.1177/17562848221117638

Chicago Style (17th ed.) Citation

Kim, Hongsik, Ryul Kim, Hyunji Jo, Hye Ryeon Kim, Joohyun Hong, Sang Yun Ha, Joon Oh Park, and Seung Tae Kim. "Expression of PD-L1 as a Predictive Marker of Sensitivity to Immune Checkpoint Inhibitors in Patients with Advanced Biliary Tract Cancer." Therapeutic Advances in Gastroenterology 15 (2022): 1. https://doi.org/10.1177/17562848221117638.

MLA (9th ed.) Citation

Kim, Hongsik, et al. "Expression of PD-L1 as a Predictive Marker of Sensitivity to Immune Checkpoint Inhibitors in Patients with Advanced Biliary Tract Cancer." Therapeutic Advances in Gastroenterology, vol. 15, 2022, p. 1, https://doi.org/10.1177/17562848221117638.